- Strong return on equity of 68.1%
- Highly efficient cash conversion (101% FCF/OCF ratio)
- Lower volatility than the market (beta 0.93)
High volatility in Trinity Biotech plc stock price on Monday which ended trading at $0.677
(Updated on Jun 15, 2026)
The Trinity Biotech plc stock price gained 4.18% on the last trading day (Monday, 15th Jun 2026), rising from $0.650 to $0.677. During the last trading day the stock fluctuated 14.53% from a day low at $0.620 to a day high of $0.710. The price has fallen in 6 of the last 10 days and is down by -5.81% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 176 thousand more shares were traded than the day before. In total, 262 thousand shares were bought and sold for approximately $177.50 thousand.
The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Trinity Biotech plc stock with a 90% probability to be traded between $0.554 and $0.758 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.
TRIB Signals & Forecast
The Trinity Biotech plc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.672 and $0.636. A breakdown below any of these levels will issue sell signals. Trinity Biotech plc has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, April 17, 2026, and so far it has fallen -9.15%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Trinity Biotech plc stock
Trinity Biotech plc finds support from accumulated volume at $0.647 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0901 between high and low, or 14.53%. For the last week, the stock has had daily average volatility of 7.49%.
Our recommended stop-loss: $0.637 (-5.88%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 40 days ago.)
Trading Expectations (TRIB) For The Upcoming Trading Day Of Tuesday 16th
For the upcoming trading day on Tuesday, 16th we expect Trinity Biotech plc to open at $0.669, and during the day (based on 14 day Average True Range), to move between $0.652 and $0.703, which gives a possible trading interval of +/-$0.0512 (+/-7.86%) up or down from last closing price. If Trinity Biotech plc takes out the full calculated possible swing range there will be an estimated 7.86% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $0.698 (3.01%) than the support at $0.647 (4.44%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Trinity Biotech plc stock A Buy?
Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Trinity Biotech plc stock to perform well in the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.
Current score:
1.323
Buy Candidate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on June 16, 2026 - $0.669 ( 1.20%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
TRIB Performance
Trading levels for TRIB
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.759 | 12.11% |
| R2 | 0.725 | 7.03% |
| R1 | 0.704 | 3.89% |
| Price | 0.677 | |
| S1 | 0.635 | -6.28% |
| S2 | 0.613 | -9.42% |
| S3 | 0.579 | -14.50% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.81 | 20.16% |
| R2 | 0.714 | 5.48% |
| R1 | 0.698 | 3.01% |
| Price | 0.677 | |
| S1 | 0.647 | -4.44% |
| S2 | 0.604 | -10.81% |
| S3 | 0.563 | -16.86% |
TRIB Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Jun 01, 2015 | Jun 05, 2015 | Jul 01, 2015 | $0.220 | 0.241% |
| 2 | May 27, 2014 | Jun 06, 2014 | Jul 01, 2014 | $0.220 | 0.187% |
| 3 | Apr 25, 2013 | Jun 06, 2013 | Jul 01, 2013 | $0.200 | 0.239% |
| 4 | Apr 25, 2012 | Jun 06, 2012 | Jun 22, 2012 | $0.150 | 0.254% |
| 5 | May 27, 2011 | Jun 07, 2011 | Jun 23, 2011 | $0.400 | 0.81% |
FAQ
Click here for our free guide on how to buy Trinity Biotech plc Stock.
Buy TRIB